Global incidence of multidrug-resistant tuberculosis

被引:378
|
作者
Zignol, Matteo [1 ]
Hosseini, Mehran S. [1 ]
Wright, Abigail [1 ]
Lambregts-van Weezenbeek, Catharina [1 ]
Nunn, Paul [1 ]
Watt, Catherine J. [1 ]
Williams, Brian G. [1 ]
Dye, Christopher [1 ]
机构
[1] World Hlth Org, Stop TB Dept, CH-1211 Geneva, Switzerland
来源
JOURNAL OF INFECTIOUS DISEASES | 2006年 / 194卷 / 04期
关键词
D O I
10.1086/505877
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The global number of incident cases of multidrug-resistant (MDR) tuberculosis (TB) in 2000 was estimated to be 272,906 (95% confidence interval [CI], 184,948-414,295). For accurate planning of TB control programs, this estimate and others have been revised using data from additional countries and by including in the model previously treated TB cases, which had not been accounted for in the previous analysis. Methods. Multiple logistic regression was used to identify variables that were predictive of MDR-TB frequency among new and previously treated cases surveyed in 90 and 77 countries, respectively. These variables were then used to estimate MDR-TB frequencies in countries that had not been surveyed. Results. The total number of MDR-TB cases estimated to have occurred worldwide in 2004 is 424,203 (95% CI, 376,019-620,061), or 4.3% (95% CI, 3.8%-6.1%) of all new and previously treated TB cases. In the same year, 181,408 (95% CI, 135,276-319,017) MDR-TB cases were estimated to have occurred among previously treated TB cases alone. Three countries-China, India, and the Russian Federation-accounted for 261,362 (95% CI, 180,779-414,749) MDR-TB cases, or 62% of the estimated global burden. Conclusions. These updated sets of estimates incorporating previously treated TB cases call for an urgent plan to expand appropriate diagnostic and treatment services for patients with MDR-TB in low-resource settings.
引用
收藏
页码:479 / 485
页数:7
相关论文
共 50 条
  • [41] Multidrug-resistant tuberculosis in India
    Tageja, Nishant
    Sharma, Vishal
    LANCET, 2010, 376 (9742): : 682 - 683
  • [42] An update on multidrug-resistant tuberculosis
    Park, Mirae
    Satta, Giovanni
    Kon, Onn Min
    CLINICAL MEDICINE, 2019, 19 (02) : 135 - 139
  • [43] Multidrug-resistant tuberculosis today
    Matteelli, A.
    Centis, R.
    D'Ambrosio, L.
    Migliori, G. B.
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2012, 90 (02) : 78 - 78
  • [44] Children and multidrug-resistant tuberculosis
    Jones, C. E.
    Kampmann, B.
    LANCET, 2011, 377 (9775): : 1404 - 1405
  • [45] TREATMENT OF MULTIDRUG-RESISTANT TUBERCULOSIS
    COHN, DL
    JOURNAL OF HOSPITAL INFECTION, 1995, 30 : 322 - 328
  • [46] MULTIDRUG-RESISTANT TUBERCULOSIS AND AIDS
    SHARP, V
    CHILIADE, P
    SEPKOWITZ, KA
    LANCET, 1994, 343 (8910): : 1431 - 1432
  • [47] Multidrug-resistant tuberculosis - Commentary
    Braden, CR
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1997, 6 (07) : 437 - 444
  • [48] Control of multidrug-resistant tuberculosis
    Weinstein, JW
    Hierholzer, WJ
    CURRENT OPINION IN INFECTIOUS DISEASES, 1996, 9 (04) : 276 - 279
  • [49] Trends in multidrug-resistant tuberculosis
    Dias-Baptista, I. M. F.
    Uso, S. M. R. S.
    Marcondes-Machado, J.
    JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES, 2008, 14 (02) : 203 - 223
  • [50] Management of multidrug-resistant tuberculosis
    Iseman, MD
    CHEMOTHERAPY, 1999, 45 : 3 - 11